Table 6. Utilization rates of ESAs according to G category and age strata.
18–44 Y | 45–64 Y | 65–74 Y | 75–84 Y | ≥85 Y | Subtotal | ||
---|---|---|---|---|---|---|---|
G3a | % | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
G3b | % | 2.2* | 0.8* | 0.8* | 0.6* | 0.7* | 0.7* |
G4 | % | 10.7* | 7.2* | 5.8* | 9.0* | 8.5* | 7.9* |
G5 | % | 23.8†* | 16.3* | 23.9†* | 29.0†* | 16.9* | 22.4* |
G4+G5 | % | 16.4†* | 10.8* | 11.6* | 13.7* | 9.6* | 12.1* |
Utilization rates are expressed as % of each population.
*:p<0.05 vs. G3a
†:p<0.05 vs. 45–64 Y.
Abbreviation: ESA, erythropoiesis-stimulating agent.